Microlax

Sodium citrate, the active ingredient in Microlax, is a laxative presented as an enema solution for rectal use. It helps relieve occasional constipation and is employed to cleanse the bowel before certain medical examinations or procedures. The formulation also contains sorbitol and sodium lauryl sulfoacetate, which together create an osmotic gradient and mild mucosal irritation to promote stool passage.

GNH USA supplies Microlax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Microlax, an osmotic laxative, is indicated for conditions that require softening of stool or cleansing of the distal colon. - Occasional constipation: provides rapid softening of stool, increases water content, and stimulates peristalsis for prompt evacuation. - Bowel preparation before diagnostic procedures: effectively cleanses the rectum and distal colon, facilitating clear imaging or endoscopic access. - Post‑operative constipation: assists in restoring regular bowel movements after surgery when mobility is reduced. - Constipation associated with limited mobility: offers quick relief for bedridden or immobile patients by promoting stool passage without systemic absorption.

Microlax may cause local and systemic reactions, most of which are mild and transient.

Common Side Effects: - Rectal irritation: mild burning or discomfort at the application site. - Abdominal cramping: brief spasms after administration. - Urgency to defecate: sudden need to evacuate stool. - Watery discharge: excess fluid may be expelled. - Nausea: mild queasiness after enema. - Dizziness: transient light‑headedness post‑administration.

Serious or Rare Side Effects: - Severe abdominal pain: intense pain requiring medical attention. - Rectal bleeding: unexpected bleeding from the rectal mucosa. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Electrolyte imbalance: rare disturbance due to excessive fluid loss.

When using Microlax, consider the following precautions to ensure safe and effective use. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: use only if the benefit outweighs potential risk to the infant. - Bowel obstruction: avoid use in patients with known intestinal blockage. - Inflammatory bowel disease flare: exercise caution during active ulcerative colitis or Crohn’s disease. - Electrolyte disorders: monitor patients prone to electrolyte imbalance, especially with repeated use. - Store at ambient temperature: keep the container tightly closed, protect from moisture and direct sunlight.

Microlax can interact with certain medications or substances, affecting efficacy or safety.

Major Interactions (Avoid): - Lithium therapy: altered renal handling may increase lithium levels, risking toxicity. - Oral rehydration salts: combined use can lead to excessive electrolyte shifts.

Moderate Interactions (Monitor Closely): - Diuretics: concurrent use may exacerbate electrolyte loss. - Other laxatives (stimulant or osmotic): risk of severe dehydration or electrolyte imbalance. - Antacids containing magnesium or aluminum: may reduce the laxative effect of Microlax.